Nguyen Thi Hue, Nguyen Thi Huyen Trang, Nguyen Anh Tuan, Pham Minh Ngoc Quang, Mai Thu Hoai, Mai Thanh Binh
{"title":"Delayed endoscopic retrograde cholangiopancreatography: a game-changer for acute cholangitis patients in a resource-limited setting.","authors":"Nguyen Thi Hue, Nguyen Thi Huyen Trang, Nguyen Anh Tuan, Pham Minh Ngoc Quang, Mai Thu Hoai, Mai Thanh Binh","doi":"10.1177/17562848251329868","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute cholangitis (AC) is a critical biliary infection caused by gallstones that can progress to systemic inflammation, sepsis, and organ failure. The 2018 Tokyo Guidelines advocate for early endoscopic retrograde cholangiopancreatography (ERCP) in moderate-to-severe AC, but its timing in resource-limited settings remains debated. In Vietnam, where healthcare resources may be limited, the timing of ERCP in patients with AC caused by gallstones has not been extensively studied.</p><p><strong>Objectives: </strong>To compare outcomes of early ERCP (eERCP, ⩽48 h) versus delayed ERCP (dERCP, >48 h) in managing stone-induced AC.</p><p><strong>Design: </strong>This was a retrospective cohort study analyzing outcomes of early versus dERCP in 708 patients with stone-induced AC. The study aimed to evaluate procedural efficacy, complications, and long-term outcomes, particularly in a resource-limited setting. Patients were stratified based on ERCP timing (⩽48 h for eERCP and >48 h for dERCP) to enable direct comparisons.</p><p><strong>Methods: </strong>Data on demographics, clinical features, laboratory findings, and procedural outcomes were analyzed.</p><p><strong>Results: </strong>The eERCP group exhibited higher rates of severe cholangitis and elevated inflammatory markers compared to the dERCP group. Intensive care unit admission rates were also higher in the eERCP group (3.1% vs 0.8%, <i>p</i> = 0.02). Perforation complications occurred more frequently in the dERCP group (1.2% vs 0%, <i>p</i> = 0.01), while stone treatment outcomes were comparable between the two groups. The eERCP group had a shorter hospital stay (6.5 vs 9.3 days, <i>p</i> < 0.05), although there were no significant differences in readmission or 1-year mortality rates. For patients with severe cholangitis, the treatment outcomes for stones, complications after intervention, and the 1-year mortality and readmission rates are similar between the two groups.</p><p><strong>Conclusion: </strong>In resource-limited settings, dERCP following resuscitation provides outcomes comparable to eERCP, offering a viable alternative when resources are constrained.</p>","PeriodicalId":48770,"journal":{"name":"Therapeutic Advances in Gastroenterology","volume":"18 ","pages":"17562848251329868"},"PeriodicalIF":3.9000,"publicationDate":"2025-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12035265/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562848251329868","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Acute cholangitis (AC) is a critical biliary infection caused by gallstones that can progress to systemic inflammation, sepsis, and organ failure. The 2018 Tokyo Guidelines advocate for early endoscopic retrograde cholangiopancreatography (ERCP) in moderate-to-severe AC, but its timing in resource-limited settings remains debated. In Vietnam, where healthcare resources may be limited, the timing of ERCP in patients with AC caused by gallstones has not been extensively studied.
Objectives: To compare outcomes of early ERCP (eERCP, ⩽48 h) versus delayed ERCP (dERCP, >48 h) in managing stone-induced AC.
Design: This was a retrospective cohort study analyzing outcomes of early versus dERCP in 708 patients with stone-induced AC. The study aimed to evaluate procedural efficacy, complications, and long-term outcomes, particularly in a resource-limited setting. Patients were stratified based on ERCP timing (⩽48 h for eERCP and >48 h for dERCP) to enable direct comparisons.
Methods: Data on demographics, clinical features, laboratory findings, and procedural outcomes were analyzed.
Results: The eERCP group exhibited higher rates of severe cholangitis and elevated inflammatory markers compared to the dERCP group. Intensive care unit admission rates were also higher in the eERCP group (3.1% vs 0.8%, p = 0.02). Perforation complications occurred more frequently in the dERCP group (1.2% vs 0%, p = 0.01), while stone treatment outcomes were comparable between the two groups. The eERCP group had a shorter hospital stay (6.5 vs 9.3 days, p < 0.05), although there were no significant differences in readmission or 1-year mortality rates. For patients with severe cholangitis, the treatment outcomes for stones, complications after intervention, and the 1-year mortality and readmission rates are similar between the two groups.
Conclusion: In resource-limited settings, dERCP following resuscitation provides outcomes comparable to eERCP, offering a viable alternative when resources are constrained.
背景:急性胆管炎(Acute cholangitis, AC)是一种由胆结石引起的严重胆道感染,可发展为全身性炎症、败血症和器官衰竭。2018年《东京指南》提倡对中度至重度AC进行早期内窥镜逆行胆管造影术(ERCP),但在资源有限的情况下,其时机仍存在争议。在越南,由于医疗资源有限,胆结石引起的AC患者ERCP的时机尚未得到广泛研究。目的:比较早期ERCP (eERCP,≤48小时)和延迟ERCP (dERCP,≤48小时)治疗结石性AC的结果。设计:这是一项回顾性队列研究,分析708例结石性AC患者早期ERCP和延迟ERCP的结果。该研究旨在评估手术疗效、并发症和长期结果,特别是在资源有限的情况下。根据ERCP时间(eERCP为48 h, dERCP为48 h)对患者进行分层,以便进行直接比较。方法:对统计资料、临床特征、实验室结果和手术结果进行分析。结果:与dERCP组相比,eERCP组表现出更高的严重胆管炎发生率和炎症标志物升高。重症监护病房住院率在eERCP组也较高(3.1% vs 0.8%, p = 0.02)。dERCP组穿孔并发症发生率更高(1.2% vs 0%, p = 0.01),两组结石治疗结果相当。结论:在资源有限的情况下,复苏后的dERCP提供了与eERCP相当的结果,在资源有限的情况下提供了一种可行的替代方案。
期刊介绍:
Therapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in gastroenterology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.
The editors welcome original research articles across all areas of gastroenterology and hepatology.
The journal publishes original research articles and review articles primarily. Original research manuscripts may include laboratory, animal or human/clinical studies – all phases. Letters to the Editor and Case Reports will also be considered.